Maker of Xanax Issues Nationwide Recall Due to Possible Presence of Foreign Substance
Mylan Pharmaceuticals, the makers of Xanax has issued a voluntary, nationwide recall of one lot of the popular anxiety medication after the discovery of a possible foreign substance that could cause an infection in some patients.
According to the Food and Drug Administration (FDA), who is helping the company spread the word about the recall, there have not been any reports of infection yet, however they're strongly encouraging consumers check their prescription package for the following lot number information:
- NDC: 0378-4003-05
- Product Description and Strength: Alprazolam Tablets, USP C-IV 0.5 mg
- Size: Bottles of 500
- Lot number: 8082708
- Expiry: September 2020
If your package contains this information, the FDA asks you "contact Stericycle at 1-888-843-0255 for the documentation packet to return product to Stericycle."
[Source: U.S. Food and Drug Administration]